Education
About Us
Working with TipRanks
Follow Us
Newcelx Ltd. (NCEL)
:NCEL
NCEL Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
NewcelX News
NCEL FAQ
What was Newcelx Ltd.’s price range in the past 12 months?
Newcelx Ltd. lowest stock price was $3.33 and its highest was $37.20 in the past 12 months.
What is Newcelx Ltd.’s market cap?
Newcelx Ltd.’s market cap is $1.56M.
When is Newcelx Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Newcelx Ltd.’s earnings last quarter?
Currently, no data Available
Is Newcelx Ltd. overvalued?
According to Wall Street analysts Newcelx Ltd.’s price is currently Undervalued.
Does Newcelx Ltd. pay dividends?
Newcelx Ltd. does not currently pay dividends.
What is Newcelx Ltd.’s EPS estimate?
Newcelx Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Newcelx Ltd. have?
Newcelx Ltd. has 425,203 shares outstanding.
What happened to Newcelx Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Newcelx Ltd.?
Currently, no hedge funds are holding shares in NCEL
Company Description
Newcelx Ltd.
Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. Its products in pipeline include AstroRx, a clinical grade human astrocytes that is in Phase 1/2a clinical trial for the treatment of amyotrophic lateral sclerosis and other neurodegenerative diseases; and IsletRx, a clinical grade pancreatic islet cell therapy treatment for diabetes. The company was incorporated in 2008 and is based in Ness Ziona, Israel.
Ownership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---